Multicenter Pilot Phase III Clinical Trial of JDP-205 iv Injection for the Treatment of Acute Urticaria Associated With an Acute Allergic Reaction.

Trial Profile

Multicenter Pilot Phase III Clinical Trial of JDP-205 iv Injection for the Treatment of Acute Urticaria Associated With an Acute Allergic Reaction.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Apr 2015

At a glance

  • Drugs Cetirizine (Primary) ; Diphenhydramine
  • Indications Hypersensitivity; Urticaria
  • Focus Registrational; Therapeutic Use
  • Acronyms ETTAU-02
  • Sponsors JDP Therapeutics
  • Most Recent Events

    • 08 Jan 2015 Top-line results published in JDP Therapeutics media release.
    • 08 Jan 2015 Primary endpoint (Reduction in Acute Urticaria symptom score) has been met, according to a JDP Therapeutics media release.
    • 08 Jan 2015 Status changed from recruiting to completed, according to a JDP Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top